Introduction
Hydrogen sulfide (H 2 S) is a ubiquitous gaseous signaling molecule that plays an important role in numerous cellular functions and has become the focus of many research endeavors, including pharmacotherapeutic manipulation [1] [2] [3] [4] [5] . Hydrogen sulfide is produced predominately from cysteine, by two pyridoxal-5 0 -phosphate-dependent enzymes, cystathionine-b-synthase and cystathionine-g-lyase, as well as by 3-mercaptosulfurtransferase. Hydrogen sulfide can diffuse across cellular membranes without the need for a specialized transporter [4, 6] . At pH 7.4 and temperature of 37 1C, 18.5% of free hydrogen sulfide exists as H 2 S gas and the remainder is almost all hydrosulfide anion (HS À ) with a negligible contribution of S 2À [7, 8] . It is long been known that the sulfur exists in the body in several forms, ranging from a fully reduced divalent state as sulfide to a fully oxidized hexavalent state as sulfate [1, 9, 10] . Measurement of biologic sulfur has focused on measuring sulfide, i.e., in the reduced divalent state, in part because of difficulties in accurately measuring other states. Additionally, sulfur equivalents in the reduced divalent state are very reactive within biological matrices, resulting in sulfide equivalents being present in various volatile sulfur pools. It is increasingly clear that these pools, in addition to free hydrogen sulfide, are important in regulating the amount of bioavailable sulfur, with the most relevant being the acid-labile and bound sulfane sulfur pools [10, 11] . Fig. 1 illustrates the various volatile sulfide pools with associated chemical species.
Sulfane sulfur refers to divalent sulfur atoms bound only to other sulfur, although they may bear an ionizable hydrogen at some pH values. These include thiosulfate S 2 O 3 2 À , persulfides 
R-S-SH, thiosulfonates R-S(O)-S-R
0 , polysulfides R-S n -R, polythionates S n O 6 2 À , and elemental sulfur S 0 [10] . Acid-labile sulfide, the other major pool, consists of sulfur present in the iron-sulfur clusters contained in iron-sulfur proteins (nonheme), which are ubiquitous in living organisms and include a variety of proteins and enzymes including rubredoxins, ferredoxins, aconitase, and succinate dehydrogenase [10, 12] . Some have claimed that the process of acid liberation may also release hydrogen sulfide from persulfides, which have traditionally been classified as sulfane sulfur [13] . This pool of sulfur has been postulated to be a ''reversible sulfide sink'' and may be an important storage pool, which regulates the amount of bioavailable free hydrogen sulfide that is available [14] , though others have suggested that bound forms may be more important in storage and release of exogenously administered sulfide [11] . The Achilles heel of the sulfide field has been the lack of precise methodology for the accurate and reproducible measurement of hydrogen sulfide both in vivo and in vitro. A variety of methods to measure free H 2 S have been employed, with divergent results [10, 13, 15] . These include a spectrophotometric derivatization method resulting in methylene blue formation, variations of this using high-performance liquid chromatography (HPLC) [10] , sulfide ion-selective electrodes, polarographic sensors [16] , gas chromatography [13, 17] , and HPLC in conjunction with fluorimetric-based methods using monobromobimane (MBB) to derivatize free H 2 S [14, 18] . The levels so determined range from nanomolar to hundreds of micromolar concentrations [10, 15] . This is due to the fact that the previously favored methylene blue method of hydrogen sulfide detection results in interference from bound sulfide pools coupled with the fact that this method is subject to chemical artifacts and unable to measure bona fide hydrogen sulfide at analytical or physiological concentrations [18] . Compelling arguments against micromolar concentrations reported by older studies [19] are further reiterated by the effect of local nanomolar concentrations affecting biologic function [20] . Indeed, the existence of storage pools of sulfide that can release H 2 S along with the volatility and spontaneous oxidation of H 2 S may help explain these apparent paradoxes.
Earlier attempts to characterize the various biologic pools of sulfur have utilized MBB in conjunction with dithiothreitol (DTT) as a reducing agent [10, 21] or have focused on the free hydrogen sulfide and acid-labile pools alone [11, 13] . These study results were limited because of various problematic issues such as pH, volatilization, and oxidation. Here we report a new protocol that measures all relevant biologic hydrogen sulfide pools, namely free hydrogen sulfide, acid-labile sulfide, and bound sulfane sulfur. The results highlight the ability to analytically and comprehensively measure hydrogen sulfide bioavailability in biologic specimens.
Principles
The fluorescent reagent MBB has been widely used to measure various thiol-containing species through alkylation [22] . S-alkylation occurs twice with sulfide under alkaline conditions, forming sulfide dibimane. Our lab has previously published an analytical method of measuring free plasma hydrogen sulfide in vivo and in vitro by derivatization of sulfide with an excess of monobromobimane under alkaline, 1% oxygen, trace-metal-free conditions with RP-HPLC separation and fluorescence detection of the sulfide dibimane product [18] .
The release of hydrogen sulfide from the acid-labile pool requires a pH less than 5.4 [11] . Thus the determination of acidlabile sulfide involves acidification of the sample, performed by adding 450 ml of 100 mM phosphate buffer (30 mM H 3 PO 4 and 70 mM KH 2 PO 4 , pH 2.6, 0.1 mM diethylenetriaminepentaacetic acid (DTPA)), causing release of free hydrogen sulfide into the headspace of a Vacutainer tube from the acid-labile pool. After removal of this solution, 100 mM Tris-HCl buffer (pH 9.5, 0.1 mM DTPA) is added and hydrogen sulfide gas is redissolved back into the buffer and the sulfide level is measured by the MBB method. The result reflects both free hydrogen sulfide and hydrogen sulfide released from the acid-labile pool.
The sulfane sulfur component is determined by treatment with tris(2-carboxyethyl)phosphine hydrochloride (TCEP), which cleaves disulfide bonds to liberate the sulfane sulfur atom. Although DTT has been used by others [10, 11, 21, 23] for this purpose, TCEP is water soluble, is nonvolatile, reduces disulfide bonds more rapidly, and has been shown to be very stable across a wide range of pH (2.0-9.5), unlike DTT [24] . TCEP also does not have a thiol moiety and has the additional advantage of not requiring removal before reaction with MBB, in contrast to DTT, which contains a thiol moiety and has been reported to have small amounts of sulfide contaminants [21] .
However, reductive dehalogenation of monobromobimane by TCEP with the creation of a fluorescent product has been reported, with the potential for interference [25] ; although this product can be extracted by methylene chloride, it is not necessary as HPLC analysis of the reaction mixture separates this product from sulfide dibimane. We found that the product of TCEP and MBB has a retention time of 11.2 min (data not shown), whereas the product of sulfide and MBB, i.e., sulfide dibimane, has a retention time of 16.5 min, and MBB alone has a retention time of 17.6 min. To overcome TCEP consumption of MBB as well as any inhibitory effects on the dye as have been reported with iodoacetamide and maleimide dyes [26] , we used a ratio of greater than 10:1 MBB to TCEP.
Persulfide formation normally occurs at alkaline pH at room temperature, and persulfide can be measured by absorbance at 335 nm using a spectrophotometer [27] . Free hydrogen sulfide released into the headspace can react with plasma proteins to form persulfide as reported below using spectrophotometry. Thus, removal of plasma from the reaction vessel after volatilization of hydrogen sulfide into the headspace is necessary before retrapping the volatilized hydrogen sulfide gas in alkaline solution for subsequent reaction with MBB. with an Agilent Eclipse XDB-C18 column (5 mm, 80Å, 4.6 Â 250 mm) equilibrated with 15% CH 3 CN in water containing 0.1% (v/v) TFA. 9) Set fluorescence detection at 390 nm (excitation) and 475 nm (emission). 10) Separate monobromobimane and sulfide dibimane using the gradient of two mobile phases identified in Table 1 , (A) water containing 0.1% (v/v) TFA and (B) 99.9% CH 3 CN, 0.1% (v/v) TFA, at a flow rate of 0.6 ml/min. 11) The retention times for the sulfide dibimane and the monobromobimane peaks are 16.5 and 17.6 min, respectively. 12) Measure the amount of hydrogen sulfide from linear plots of the HPLC peak areas of sulfide dibimane versus known concentration of sulfide solution.
Effect of plasma protein on trapping volatilized hydrogen sulfide
To test the interaction of plasma proteins with the released hydrogen sulfide in the headspace of the Vacutainer during alkaline retrapping, we determined the amount of hydrogen sulfide detected when the plasma was retained in the Vacutainer as opposed to removal and measured the formation of persulfides in the plasma. Sample preparation for detecting acid-labile sulfide and bound sulfane sulfur 1) Add 50 ml of plasma separately into two sets of 4-ml BD Vacutainer tubes.
2) Add 450 ml of 100 mM phosphate buffer (pH 2.6, 0.1 mM DTPA) to one tube and to the other add 450 ml of 100 mM phosphate buffer (pH 2.6, 0.1 mM DTPA, and 1 mM TCEP). 3) Incubate these tubes on the nutator for 30 min. 4) Remove the solution through the cap with a 25-gauge spinal needle or other similar long needle and 1-ml plastic syringe.
5) Trap the sulfide gas by adding 500 ml of 100 mM Tris-HCl buffer (pH 9.5, 0.1 mM DTPA) into the BD Vacutainer tube, using a 30-gauge needle, and incubating for 30 min on the nutator. 6) Remove the solution and measure the sulfide level in the BD Vacutainer tube by the MBB method. 7) Calculate the acid-labile sulfide and sulfane sulfur pools: a. Acid-labile sulfide is the value obtained using the acidliberation protocol minus the free hydrogen sulfide value. b. Bound sulfane sulfur is the value obtained from TCEP treatment minus the value obtained using the acid-liberation protocol.
Similarly, to optimize the effects of other experimental conditions, hydrogen sulfide can be released and trapped under various conditions including 0-1 h releasing time, 0-1 h reducing time, and 0-1 h trapping time in the hypoxic chamber.
Animal and human approvals
The use of animals for this study was approved by the Institutional Animal Care and Use Committee of the Louisiana State University (LSU) Health-Shreveport (Shreveport, LA, USA) via Protocol P-12-011. All animals received humane care in compliance with the Guide for the Care and Use of Laboratory Animals. The enrollment of male healthy human subjects was approved by the Institutional Review Board of LSU Health-Shreveport via Protocol H11-110. Human subjects were males between 23 and 34 years of age.
Calculations and results

Measurement techniques for analyzing acid-labile sulfide and bound sulfane sulfur
To establish the efficiency of the acid-liberation technique and alkaline Tris-HCl buffer trapping of the headspace sulfide gas, we sought to determine the optimal trapping time with a known molar solution of sodium sulfide. As demonstrated in Fig. 2(A) , the highest recovery percentage was achieved after 30 min of trapping headspace sulfide gas, establishing this time frame as optimal. Next we sought to demonstrate that percentage recovery of acid volatilized hydrogen sulfide was optimal, as demonstrated in Fig. 2(B) , in which the sulfide content of a known molar solution of sodium sulfide was measured directly and after acid release and alkaline retrapping. Next, we sought to identify the optimal time for release of hydrogen sulfide after acidification of plasma, as shown in Fig. 2(C) . Plasma acid-labile sulfide is maximally released after incubation with 100 mM phosphate buffer (pH 2.6) for 30 min. Therefore, 30 min of releasing time and 30 min of trapping time were applied in all the subsequent experiments. Furthermore, the residual hydrogen sulfide in the plasma after volatilization by acidification was measured and found to be 0.012570.0029 mM, which is slightly above the reaction solution background level, 0.0072570.0018 mM. This does not represent a significant fraction of H 2 S detected in the headspace after acid volatilization.
Effect of plasma proteins on trapped hydrogen sulfide
To determine the potential reaction between plasma proteins and volatilized hydrogen sulfide, headspace hydrogen sulfide gas was trapped in 100 mM Tris-HCl buffer (pH 9.5, 0.1 mM DTPA) without and with removal of plasma. Fig. 3(A) demonstrates that the measured hydrogen sulfide is decreased when the trapping process occurs with the plasma remaining in the reaction vessel as opposed to removal and replacement with the 100 mM TrisHCl (pH 9.5) buffer. We confirmed that this loss of hydrogen sulfide is attributable to the formation of protein persulfides by measurement of persulfide formation using the cyanolysis method compared to known molar concentrations of sodium sulfide reacted with plasma ( Fig. 3(B) and (C)).
Effect of TCEP on sulfane sulfur reduction and MBB derivatization reaction of hydrogen sulfide TCEP is a strong reducing agent and can react with MBB as mentioned above. Therefore, the effects of various concentrations of TCEP on sulfide derivatization were studied. Before sulfide derivatization, 50 or 1 mM TCEP was added to the sulfide stock solution containing 40 mM sodium sulfide. Fig. 4(A) and (B) demonstrate that TCEP can affect the sulfide-monobromobimane reaction in the presence of 50 mM TCEP, but there is no significant effect in the presence of 1 mM TCEP. We postulate that at higher TCEP concentrations, the TCEP reaction with MBB limits the amount of MBB available to react with sulfide, hence the importance of maintaining a ratio of 1:10 TCEP to MBB.
Diallyl trisulfide (DATS) is an organic polysulfide compound found in garlic that acts as a sulfide donor. DATS was used to verify the efficiency of TCEP reduction of the disulfide bonds. Fig. 4(C) shows that 95% of DATS is reduced to free sulfide after incubation with 100 mM phosphate buffer (pH 2.6, 0.1 mM DTPA and 1 mM TCEP) for 30 min. Fig. 4(D) demonstrates that DATS is stable in the absence of TCEP but with TCEP there is complete reduction of and an expected release of hydrogen sulfide with 100 mM phosphate buffer (pH 2.6, 0.1 mM DTPA and 1 mM TCEP) for 30 min. This was demonstrated both in solution alone and in a mixture of 5 mM sodium sulfide plus 25 mM DATS.
We next examined the stability of the sulfide-dibimane product (SDB) in the presence of TCEP. The reaction between hydrogen sulfide and MBB occurs under alkaline conditions and is then terminated and stabilized with 200 mM sulfosalicylic acid. Fig. 4(E) shows that hydrolysis of the SDB is increased at pH 9.5 in the presence of 1 or 0 mM TCEP, with only 5% SDB remaining after a 20-h incubation. In the acid buffer, however, SDB is stable at 4 1C in the presence of 1 or 0 mM TCEP.
Comparison of free sulfide, acid-labile sulfide, and bound sulfane sulfur in murine and human plasma samples Free sulfide, acid-labile sulfide, and bound sulfane sulfur levels were measured in the plasma of wild-type C57BL/6J, CSE genedeficient mice and healthy human volunteers. Fig. 5(A) shows that CSE knockout mice, known to be defective in hydrogen sulfide production, show a significant decrease in free and acidlabile sulfide compared to wild-type mice, but no significant difference in bound sulfane sulfur. In Fig. 5(B) , we show that the free hydrogen sulfide pool in plasma from healthy human volunteers is in the low-nanomolar range but that the acid-labile pool is in the low-micromolar range. The bound sulfane sulfur pool was significantly smaller, similar to the murine models. The low-micromolar levels of the acid-labile pool in plasma from both mice and humans, in contrast to the high-nanomolar levels of free hydrogen sulfide, support the theory of a reversible sulfide sink into and from which hydrogen sulfide can be stored or released to effect biologic functions.
Caveats
Important general experimental considerations with respect to hydrogen sulfide measurement [13, 18] volatilization and the transfer of reagents and solutions is done via a needle inserted into the rubber stop-cock of the vacuum tubes, hence avoiding loss of vacuum and gas samples [31] . 2) Binding of H 2 S to experimental vessels is minimized by using polypropylene reaction vessels. 3) Lithium heparin is used as anticoagulant as it has been shown to be less prone to causing hemolysis than EDTA [32] . 4) Samples should be transported at 4 1C to minimize enzymatic production or degradation of hydrogen sulfide. 5) MBB is a light-sensitive reagent, so derivatization should be performed in the dark. 6) A 1% oxygen environment is maintained throughout the reaction protocol with acid and reducing agents as well as the MBB reaction process.
Conclusion
The field of hydrogen sulfide measurement continues to evolve, with modifications of various methods, reports of various fluorescent probes [33] [34] [35] , and applications of new technologies such as nanotubes and quantum dots [36, 37] . The new method described here (Fig. 6 ) opens the door to accurate, quantitative, and scalable measurement of discrete pools of hydrogen sulfide from primary volatile sulfide pools. Use of this protocol on both experimental and clinical specimens will further enhance our understanding of hydrogen sulfide bioavailable equivalents during pathophysiological events and provide a critical analytical detection method for pharmacologic endeavors to manipulate the levels of hydrogen sulfide for therapeutic purposes. 
